Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

Gene Therapy for Neurological Disorders

Evvnt Promotion / evvnt
-
06.12.2021 - 09.12.2021  The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:30 am - 5:30 pm
 
Temi della conferenza
Returning to Boston this December, the 3rd Gene Therapy for Neurological Disorders meeting will welcome discovery, preclinical, translational and clinical industry scientists to share, learn and network for the shared goal of successfully and safely delivering gene therapies to the CNS.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/853497-0?pid=4832

Speakers: Alan Foster, Chief Scientific Officer, Otonomy, Inc., Alexandra Watt, Lead Research Analyst, Beacon Targeted Therapies and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/853497-1?pid=4832
Ms. Ellie Saunders
 
Categorie
Medicina General, Ricerca clinica
Lingua
Inglese
Quote del Congresso
Full Access Pass - Physical - Standard Rate: USD 3593.00, Conference + Workshop Day OR Post Event Delivery Day - Physical - Standard Rate: USD 2846.00, Conference Only - Physical - Standard Rate: USD 2099.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichische Akademie der ÄrzteAnästhesie in Entwicklungsländern e. V.AGEM - Arbeitsgemeinschaft Ethnologie und MedizinEuropean Health Forum GasteinSwiss Tropical and Public Health InstituteÖsterreichische Gesellschaft für Public HealthnewTree